Skip to main content
PMC home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1996 Sep;5(9):1883–1889. doi: 10.1002/pro.5560050914

Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.

M J Heeb 1, Y Kojima 1, T M Hackeng 1, J H Griffin 1
PMCID: PMC2143529  PMID: 8880912

Abstract

Inactivation due to cleavage of Factor Va (FVa) at Arg 506 by activated protein C (APC) helps to downregulate blood coagulation. To identify potential functional roles of amino acids near Arg 506, synthetic overlapping pentadecapeptides comprising FVa heavy chain residues 481-525 were tested for their ability to inhibit prothrombin activation by prothrombinase complexes [Factor Xa (FXa):FVa:phospholipids:Ca2+]. The most potent inhibition was observed for peptide VP493 (residues 493-506), with 50% inhibition at 2.5 microM. VP493 also inhibited FXa in plasma in FXa-1-stage clotting assays by 50% at 3 microM. When the C-terminal carboxamide group of VP493 was replaced by a carboxyl group, most prothrombinase inhibitory activity was lost. VP493 preincubated with FXa inhibited prothrombinase with a pattern of mixed inhibition. Homologous peptides from Factor VIII sequences did not inhibit prothrombinase. Affinity-purified antibodies to VP493 inhibited prothrombinase activity and prolonged FXa-1-stage clotting times. VP493 also blocked the ability of protein S to inhibit prothrombinase independently of APC. Immobilized VP493 bound specifically with similar affinity to both FXa and protein S (Kd approximately 40 nM), but did not measurably bind prothrombin or APC. These studies suggest that FVa residues 493-506 contribute to binding sites for both FXa and protein S, providing a rationale for the ability of protein S to negate the protective effect of FXa toward APC cleavage of FVa. Possible loss of this FVa binding site for FXa due to cleavage at Arg 506 by APC may help explain why this cleavage causes 40% decrease in FVa activity and facilitates inactivation of FVa.

Full Text

The Full Text of this article is available as a PDF (648.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dahlbäck B., Carlsson M., Svensson P. J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1004–1008. doi: 10.1073/pnas.90.3.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood. 1995 Feb 1;85(3):607–614. [PubMed] [Google Scholar]
  3. Fay P. J., Beattie T., Huggins C. F., Regan L. M. Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site. J Biol Chem. 1994 Aug 12;269(32):20522–20527. [PubMed] [Google Scholar]
  4. Greengard J. S., Sun X., Xu X., Fernandez J. A., Griffin J. H., Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet. 1994 May 28;343(8909):1361–1362. doi: 10.1016/s0140-6736(94)92497-x. [DOI] [PubMed] [Google Scholar]
  5. Griffin J. H., Evatt B., Wideman C., Fernández J. A. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood. 1993 Oct 1;82(7):1989–1993. [PubMed] [Google Scholar]
  6. Guinto E. R., Esmon C. T. Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C. J Biol Chem. 1984 Nov 25;259(22):13986–13992. [PubMed] [Google Scholar]
  7. Hackeng T. M., van 't Veer C., Meijers J. C., Bouma B. N. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. J Biol Chem. 1994 Aug 19;269(33):21051–21058. [PubMed] [Google Scholar]
  8. Heeb M. J., Rosing J., Bakker H. M., Fernandez J. A., Tans G., Griffin J. H. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2728–2732. doi: 10.1073/pnas.91.7.2728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Houghten R. A. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5131–5135. doi: 10.1073/pnas.82.15.5131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jane S. M., Hau L., Salem H. H. Regulation of activated protein C by factor Xa. Blood Coagul Fibrinolysis. 1991 Dec;2(6):723–729. doi: 10.1097/00001721-199112000-00005. [DOI] [PubMed] [Google Scholar]
  11. Kalafatis M., Bertina R. M., Rand M. D., Mann K. G. Characterization of the molecular defect in factor VR506Q. J Biol Chem. 1995 Feb 24;270(8):4053–4057. doi: 10.1074/jbc.270.8.4053. [DOI] [PubMed] [Google Scholar]
  12. Kalafatis M., Rand M. D., Mann K. G. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem. 1994 Dec 16;269(50):31869–31880. [PubMed] [Google Scholar]
  13. Kalafatis M., Xue J., Lawler C. M., Mann K. G. Contribution of the heavy and light chains of factor Va to the interaction with factor Xa. Biochemistry. 1994 May 31;33(21):6538–6545. doi: 10.1021/bi00187a022. [DOI] [PubMed] [Google Scholar]
  14. Koster T., Rosendaal F. R., de Ronde H., Briët E., Vandenbroucke J. P., Bertina R. M. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993 Dec 18;342(8886-8887):1503–1506. doi: 10.1016/s0140-6736(05)80081-9. [DOI] [PubMed] [Google Scholar]
  15. Krishnaswamy S., Church W. R., Nesheim M. E., Mann K. G. Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. J Biol Chem. 1987 Mar 5;262(7):3291–3299. [PubMed] [Google Scholar]
  16. Krishnaswamy S., Williams E. B., Mann K. G. The binding of activated protein C to factors V and Va. J Biol Chem. 1986 Jul 25;261(21):9684–9693. [PubMed] [Google Scholar]
  17. Mann K. G., Nesheim M. E., Hibbard L. S., Tracy P. B. The role of factor V in the assembly of the prothrombinase complex. Ann N Y Acad Sci. 1981;370:378–388. doi: 10.1111/j.1749-6632.1981.tb29750.x. [DOI] [PubMed] [Google Scholar]
  18. Mesters R. M., Heeb M. J., Griffin J. H. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va. Biochemistry. 1993 Nov 30;32(47):12656–12663. doi: 10.1021/bi00210a014. [DOI] [PubMed] [Google Scholar]
  19. Mesters R. M., Heeb M. J., Griffin J. H. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C. Protein Sci. 1993 Sep;2(9):1482–1489. doi: 10.1002/pro.5560020912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mesters R. M., Houghten R. A., Griffin J. H. Identification of a sequence of human activated protein C (residues 390-404) essential for its anticoagulant activity. J Biol Chem. 1991 Dec 25;266(36):24514–24519. [PubMed] [Google Scholar]
  21. O'Brien L. M., Medved L. V., Fay P. J. Localization of factor IXa and factor VIIIa interactive sites. J Biol Chem. 1995 Nov 10;270(45):27087–27092. doi: 10.1074/jbc.270.45.27087. [DOI] [PubMed] [Google Scholar]
  22. Odegaard B., Mann K. Proteolysis of factor Va by factor Xa and activated protein C. J Biol Chem. 1987 Aug 15;262(23):11233–11238. [PubMed] [Google Scholar]
  23. Pan Y., DeFay T., Gitschier J., Cohen F. E. Proposed structure of the A domains of factor VIII by homology modelling. Nat Struct Biol. 1995 Sep;2(9):740–744. doi: 10.1038/nsb0995-740. [DOI] [PubMed] [Google Scholar]
  24. Rosing J., Hoekema L., Nicolaes G. A., Thomassen M. C., Hemker H. C., Varadi K., Schwarz H. P., Tans G. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem. 1995 Nov 17;270(46):27852–27858. doi: 10.1074/jbc.270.46.27852. [DOI] [PubMed] [Google Scholar]
  25. Rosing J., Tans G., Govers-Riemslag J. W., Zwaal R. F., Hemker H. C. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem. 1980 Jan 10;255(1):274–283. [PubMed] [Google Scholar]
  26. Solymoss S., Tucker M. M., Tracy P. B. Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection. J Biol Chem. 1988 Oct 15;263(29):14884–14890. [PubMed] [Google Scholar]
  27. Sun X., Evatt B., Griffin J. H. Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood. 1994 Jun 1;83(11):3120–3125. [PubMed] [Google Scholar]
  28. Suzuki K., Stenflo J., Dahlbäck B., Teodorsson B. Inactivation of human coagulation factor V by activated protein C. J Biol Chem. 1983 Feb 10;258(3):1914–1920. [PubMed] [Google Scholar]
  29. Svensson P. J., Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994 Feb 24;330(8):517–522. doi: 10.1056/NEJM199402243300801. [DOI] [PubMed] [Google Scholar]
  30. Tracy P. B., Mann K. G. Prothrombinase complex assembly on the platelet surface is mediated through the 74,000-dalton component of factor Va. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2380–2384. doi: 10.1073/pnas.80.8.2380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tucker M. M., Foster W. B., Katzmann J. A., Mann K. G. A monoclonal antibody which inhibits the factor Va:factor Xa interaction. J Biol Chem. 1983 Jan 25;258(2):1210–1214. [PubMed] [Google Scholar]
  32. Voorberg J., Roelse J., Koopman R., Büller H., Berends F., ten Cate J. W., Mertens K., van Mourik J. A. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Lancet. 1994 Jun 18;343(8912):1535–1536. doi: 10.1016/s0140-6736(94)92939-4. [DOI] [PubMed] [Google Scholar]
  33. Walker F. J., Scandella D., Fay P. J. Identification of the binding site for activated protein C on the light chain of factors V and VIII. J Biol Chem. 1990 Jan 25;265(3):1484–1489. [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES